Subtype-specific prognostic impact of different immune signatures in node-negative breast cancer.
Heimes AS, Madjar K, Edlund K, Battista MJ, Almstedt K, Elger T, Krajnak S, Rahnenführer J, Brenner W, Hasenburg A, Hengstler JG, Schmidt M.
Heimes AS, et al. Among authors: elger t.
Breast Cancer Res Treat. 2017 Sep;165(2):293-300. doi: 10.1007/s10549-017-4327-0. Epub 2017 Jun 5.
Breast Cancer Res Treat. 2017.
PMID: 28585074